Y-mAbs Therapeutics, Inc. logo

Y-mAbs Therapeutics, Inc.

YMABNASDAQ

Y-mAbs Therapeutics, Inc. is a biotechnology company in the healthcare sector on NASDAQ, led by Michael Rossi, with a market cap of $391.2M. As of Q3 2025, 0% of shares are held by 2 institutional investors, with Skopos Labs, Inc. as the largest holder at -.

President and Chief Executive OfficerMichael Rossi
Market Cap$391.2M
Biotechnology
Healthcare
Employees100.0
Websiteymabs.com
Country
United States of America

Overview

Overview of institutional ownership in YMAB as of Q3 2025 with a market cap of $391.2M

All Institutions

Institutions
2
Value Held
$78.3K
Shares Held
16.4K
Avg Position
$39.2K
Median Position
$39.2K

Hedge Funds

Hedge Funds
0
Value Held
-
Shares Held
-
Avg Position
-
Median Position
-

Ownership Breakdown

Institutional (non-HF): 0.02%Hedge Funds: -Retail & Other: 99.98%Retail & Other
Institutional (non-HF)
0.02%
$78.3K
Hedge Funds
-
-
Retail & Other
99.98%
$391.1M

Based on market cap of $391.2M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in YMAB as of Q3 2025

InstitutionPosition Value
$75.5K
0.01% of portfolio
$2.9K
0.00% of portfolio
TWO SIGMA ADVISERS, LLC logo
TWO SIGMA ADVISERS, LLC
Hedge FundMulti-Strategy
-
0.00% of portfolio
CWM, LLC logo
CWM, LLC
RIA/Wealth
-
0.00% of portfolio
-
0.00% of portfolio
-
0.00% of portfolio
-
0.00% of portfolio
GSA CAPITAL PARTNERS LLP logo
GSA CAPITAL PARTNERS LLP
Hedge FundQuant
-
0.00% of portfolio
-
0.00% of portfolio
-
0.00% of portfolio

Net Capital Flow

Institutional buying and selling activity for YMAB in Q3 2025

Traded
$125.8M
Buyers
1
Sellers
95
Total Bought
+$52.2K
Total Sold
$125.8M
Avg Position
$816.1

Biggest Buyers

InstitutionNet Bought
+$52.2K
+11.1K shares

Biggest Sellers

InstitutionNet Sold
Paradigm Biocapital Advisors LP logo
Paradigm Biocapital Advisors LP
Hedge FundLong/Short
$19.1M
4.2M shares
$15.4M
3.4M shares
B
BlackRock, Inc.
Institution
$12.4M
2.7M shares
C
Caligan Partners LP
Hedge FundActivist
$10.6M
2.3M shares
S
Sofinnova Ventures Inc
Venture Capital
$9.9M
2.2M shares
$8.8M
1.9M shares
$8.1M
1.8M shares
$3.8M
848.5K shares
$3.5M
780.1K shares
$3.1M
693.7K shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited YMAB in Q3 2025

New Positions
0
New Value
-
Exited Positions
94
Exited Value
$125.8M

New Positions

InstitutionPosition Value
No new positions found

Exited Positions

InstitutionPrevious Position
Paradigm Biocapital Advisors LP logo
Paradigm Biocapital Advisors LP
Hedge FundLong/Short
$19.1M
4.2M shares
$15.4M
3.4M shares
B
BlackRock, Inc.
Institution
$12.4M
2.7M shares
C
Caligan Partners LP
Hedge FundActivist
$10.6M
2.3M shares
S
Sofinnova Ventures Inc
Venture Capital
$9.9M
2.2M shares
$8.8M
1.9M shares
$8.1M
1.8M shares
$3.8M
848.5K shares
$3.5M
780.1K shares
$3.1M
693.7K shares

Options Activity

Institutions with the largest Call and Put options positions in YMAB as of Q3 2025

Call Positions
1
Call Value
-
Put Positions
0
Put Value
-

Call Positions

InstitutionPosition Value
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
-
- contracts

Put Positions

InstitutionPosition Value
No put positions found

Most Committed Institutions

Institutions with YMAB as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
0.01%
$75.5K
0.00%
$2.9K
TWO SIGMA ADVISERS, LLC logo
TWO SIGMA ADVISERS, LLC
Hedge FundMulti-Strategy
0.00%
-
CWM, LLC logo
CWM, LLC
RIA/Wealth
0.00%
-
0.00%
-
0.00%
-
0.00%
-
GSA CAPITAL PARTNERS LLP logo
GSA CAPITAL PARTNERS LLP
Hedge FundQuant
0.00%
-
0.00%
-
0.00%
-

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.